Ziopharm Oncology Announces Recent Publications in Peer-Reviewed Scientific Journals

    NEXT STORY
    Surgical Tables Market to Reach USD 1,204.2 Million by 2026; Launch of Allen Advance Table Lateral System Will Bolster Growth, sates Fortune Business Insights™
    PREV STORY
    OpGen Provides Update on Curetis Group Company Ares Genetics’ Collaboration with BGI Group to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022

    author_avatar
    NASDAQ Market News

    Mereo BioPharma Group Plc (“Mereo” or the “Company” or the “Group”) Preliminary Results for the Year Ended December 31, 2018 — Strong Operational Progress

    author_avatar
    NASDAQ Market News

    OncoMed Initiates Phase 1b Immuno-Oncology Combination Clinical Trial for Demcizumab and Pembrolizumab (anti-PD1)

    REDWOOD CITY, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a ...

    author_avatar
    NASDAQ Market News